vimarsana.com

Page 2 - மனிதன் ஆராய்ச்சி நெறிமுறைகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anatara Lifesciences Limited | Company Summary | ASX:ANR ISIN:AU000000ANR0 | Australian Stock Exchange ABN Newswire

Anatara is pleased that activities for the March quarter progressed favourably and near to anticipated timelines. There appears to be a wider appreciation of Anatara s human health initiatives with a focus on using the restoration and/or maintenance of gastrointestinal tract harmony to improve overall wellbeing.Read Full Article▸ On 14 December 2020, Anatara Lifesciences Limited (ASX:ANR) announced details of an off-market share buy-back facility (Buy-Back Facility) to buyback all of the shares held by shareholders who held unmarketable parcels of shares in the Company.Read Full Article▸ Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial of its Gastrointestinal Re-Programming complementary medicine (GaRP) in participants with irritable bowel syndrome - diarrhoea subtype (IBS-D).Read Full Article▸

Managing Refusal of Medical Care in Older Adults - CIA

23 Treatment refusal can occur in the presence or absence of decision-making capacity. 24 The core elements of capacity are the ability to understand the information relevant to the decision, the ability to use or weigh that information as part of the decision-making process, and to communicate the decision. 25 Common law establishes that an adult is presumed to have the capacity to consent to or refuse medical treatment unless that presumption is rebutted. 26 However, capacity may be affected by symptoms of mental and physical illness, emotional state and cognition, which may fluctuate over time and resolve with treatment and support. 27,28 With psychosis, for example, there may be symptoms such as delusional beliefs leading to mistrust of clinicians or denial of illness.

Frontiers | All Plant Breeding Technologies Are Equal, but Some Are More Equal Than Others: The Case of GM and Mutagenesis

2School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia A pervasive opposition to genetically modified (GM) foods has developed from the notion that they pose a risk to human and environmental health. Other techniques for the genetic modification of plants, such as sexual crossing and mutagenesis breeding, have mostly remained unchallenged. This research aims to investigate public perception of plant breeding technologies. Specifically, sexual crossing, mutagenesis, transgenics (GM) and gene editing. It was expected that attitudes and intentions would be most positive and the perception of risk lowest for plant genetic modification through sexual crosses. Scores on these variables were expected to be similar between mutagenesis, GM and gene editing. It was also expected that attitudes, intentions and risk perception would change (becoming more positive) once participants learned about foods developed through these technologies. Participants reported

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.